Rajesh Balakrishnan
Overview
Explore the profile of Rajesh Balakrishnan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
80
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Naik Y, Kulkarni U, Lionel S, Selvarajan S, Devasia A, Korula A, et al.
Transplant Cell Ther
. 2024 Oct;
31(1):22.e1-22.e10.
PMID: 39419176
Total marrow and lymphoid irradiation (TMLI) can deliver higher doses of irradiation without increased toxicity. This study evaluated TMLI and cyclophosphamide in patients undergoing stem cell transplantation for acute lymphoblastic...
2.
B S, Backianathan S, Rafic K M, T J, Susan Varghese S, S P, et al.
Asian Pac J Cancer Prev
. 2024 Sep;
25(9):3301-3310.
PMID: 39342610
Background: In the context of left breast cancer radiotherapy, long term cardiopulmonary toxicity has been well-documented, significant efforts have been undertaken to mitigate such toxicity by using 4D gating, deep...
3.
Rahman M, Balakrishnan R, Mostofa M, Islam M, Kabir E, Islam M, et al.
Cancer Rep (Hoboken)
. 2024 Sep;
7(9):e70020.
PMID: 39324687
Background: Squamous cell carcinoma (SCC) is a rare malignancy of invasive epithelium with keratinocyte differentiation, and it is the most common form of eyelid malignant neoplasm, comprising 5%-10% of malignancies....
4.
Singh A, Georgy J, Joel A, Thumaty D, John A, Ramnath N, et al.
Cancer Invest
. 2023 Nov;
41(9):789-802.
PMID: 37909664
We assessed the efficacy, tolerability, and cost-effectiveness of a novel neoadjuvant regimen comprising docetaxel-cyclophosphamide alternating with epirubicin-cisplatin (ddDCEP) administered biweekly for 16 weeks in 116 patients with early triple-negative breast...
5.
Ganesh S, Jasper A, Backianathan S, Moorthy R, Balakrishnan R, Sebastian P, et al.
World Neurosurg
. 2023 Jul;
178:e189-e201.
PMID: 37454908
Objective: We studied the correlation between new-onset perinidal hyperintensity (PH) on T2-weighted magnetic resonance imaging and obliteration of intracranial arteriovenous malformation (AVM) after stereotactic radiosurgery (SRS). Methods: A retrospective study...
6.
Godson H, Raj J, Sebastian P, Ponmalar R, Babu E, Paul I, et al.
Strahlenther Onkol
. 2023 Jun;
199(10):922-935.
PMID: 37278833
Purpose: Total marrow lymphoid irradiation (TMLI) with volumetric modulated arc therapy (VMAT) is challenging due to large treatment fields with multiple isocenters, field matching at junctions, and targets being surrounded...
7.
George B, Balakrishnan R, S P, Lionel S, Selvarajan S, Devasia A, et al.
Clin Transplant
. 2023 May;
37(9):e15010.
PMID: 37144852
Introduction: Total marrow lymphoid irradiation (TMLI) can deliver higher doses of irradiation without increasing toxicity compared to Total body irradiation (TBI). Methods: Twenty adult patients undergoing hematopoietic stem cell transplantation...
8.
Sarkar S, Korula S, Mathai S, Simon A, Balakrishnan R, Backianathan S, et al.
Childs Nerv Syst
. 2022 Aug;
38(10):1877-1883.
PMID: 35945339
Objective: Incomplete surgical removal of craniopharyngiomas frequently results in suboptimal oncological control. Radiation therapy is usually offered in these cases to prevent local recurrence of disease; however, the efficacy of...
9.
Balakumar S, Pai R, Chacko A, Patel B, Nancy R, Balakrishnan R, et al.
Neurol India
. 2022 Jul;
70(3):953-959.
PMID: 35864624
Background: Introduction: Gliomas were previously classified histologically, although now the latest WHO classification incorporates several molecular markers to classify these. Detection of TERT promoter mutations is assuming increased importance due...
10.
Goyal-Honavar A, Balasundaram A, Thayakaran I, Babu M, Pai R, Joseph J, et al.
World Neurosurg
. 2022 Apr;
164:e82-e90.
PMID: 35378317
Background: Supratentorial ependymomas (STEs) are an aggressive group of ependymomas, topographically distinct from their posterior fossa and spinal counterparts. Zinc finger translocation associated (ZFTA) fusion-positive cases have been reported to...